Literature DB >> 3556994

Biliary proteins and the nucleation defect in cholesterol cholelithiasis.

S Gallinger, P R Harvey, C N Petrunka, R G Ilson, S M Strasberg.   

Abstract

A study was performed to determine whether differences in gallbladder proteins might be present in patients with rapidly nucleating bile. Gallbladder and hepatic bile protein concentrations were measured using a fluorometric assay. The method was validated by an independent technique, i.e., hydrolysis and amino acid analysis. Persons with cholesterol gallstones had significantly higher gallbladder bile protein concentrations than patients without gallbladder disease or patients with pigment stones. The protein concentration correlated with the in vitro nucleation time in the cholesterol stone group. Gallbladder bile proteins were also purified by chromatography and gradient ultracentrifugation. Proteins from patients with cholesterol gallstones accelerated the nucleation time of control bile, whereas protein from controls had little effect. Hepatic bile protein concentrations were similar in persons with and without cholesterol gallstones. The gallbladder-to-hepatic bile ratios of a variety of solutes were examined. The ratio for protein in the cholesterol gallstone group can be explained straightforwardly by water reabsorption in the gallbladder, whereas the very low ratio in patients without cholesterol gallstones suggests that their gallbladders reduce protein mass by a process such as protein absorption or degradation during water absorption in the gallbladder.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556994     DOI: 10.1016/0016-5085(87)90959-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Comparative study of changing patterns of concanavalin A-binding proteins in early stage of cholesterol gallstone formation.

Authors:  Y Q Chen; D Cai; Y L Zhang; T F Hua
Journal:  World J Gastroenterol       Date:  1997-12-15       Impact factor: 5.742

2.  Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.

Authors:  S Sahlin; J Ahlberg; K Einarsson; R Henriksson; A Danielsson
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

3.  Decreased protein concentration and improved metastability of bile induced by ursodeoxycholate.

Authors:  K Chijiwa; I Hirota; H Noshiro
Journal:  Gastroenterol Jpn       Date:  1992-02

4.  Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy.

Authors:  F Lammert; S Südfeld; N Busch; S Matern
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization.

Authors:  N Busch; F Lammert; H U Marschall; S Matern
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis.

Authors:  L Núñez; L Amigo; G Mingrone; A Rigotti; L Puglielli; A Raddatz; F Pimentel; A V Greco; S González; J Garrido
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

7.  Increased biliary protein precedes gallstone formation.

Authors:  A J Moser; M Z Abedin; J J Roslyn
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Qualitative and quantitative comparison of gallbladder proteins from patients with and without cholesterol gallstones.

Authors:  L Yu
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

9.  Total protein output during rapid reduction of bile salt secretion rates in man.

Authors:  P R Harvey; J L Toth; G A Upadhya; R G Ilson; S M Strasberg
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

10.  Gallbladder mucosal protein secretion during development of experimental cholecystitis.

Authors:  D L Kaminski; Y G Deshpande; A Li; F Dysart; M Nag
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.